[go: up one dir, main page]

BRPI0810881A2 - Uso de bactérias do ácido lático selecionadas para redução da aterosclerose - Google Patents

Uso de bactérias do ácido lático selecionadas para redução da aterosclerose

Info

Publication number
BRPI0810881A2
BRPI0810881A2 BRPI0810881-1A2A BRPI0810881A BRPI0810881A2 BR PI0810881 A2 BRPI0810881 A2 BR PI0810881A2 BR PI0810881 A BRPI0810881 A BR PI0810881A BR PI0810881 A2 BRPI0810881 A2 BR PI0810881A2
Authority
BR
Brazil
Prior art keywords
lactic acid
acid bacteria
selected lactic
reduce atherosclerosis
atherosclerosis
Prior art date
Application number
BRPI0810881-1A2A
Other languages
English (en)
Inventor
Peter Rothschild
Eamonn Connolly
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of BRPI0810881A2 publication Critical patent/BRPI0810881A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0810881-1A2A 2007-04-11 2008-03-05 Uso de bactérias do ácido lático selecionadas para redução da aterosclerose BRPI0810881A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/786,356 US20080254011A1 (en) 2007-04-11 2007-04-11 Use of selected lactic acid bacteria for reducing atherosclerosis
PCT/SE2008/050248 WO2008127180A1 (en) 2007-04-11 2008-03-05 Use of selected lactic acid bacteria for reducing atherosclerosis

Publications (1)

Publication Number Publication Date
BRPI0810881A2 true BRPI0810881A2 (pt) 2014-10-21

Family

ID=39853915

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810881-1A2A BRPI0810881A2 (pt) 2007-04-11 2008-03-05 Uso de bactérias do ácido lático selecionadas para redução da aterosclerose

Country Status (11)

Country Link
US (2) US20080254011A1 (pt)
EP (1) EP2136824A4 (pt)
JP (1) JP2010523144A (pt)
KR (1) KR20100015371A (pt)
CN (1) CN101702881A (pt)
AU (1) AU2008239833A1 (pt)
BR (1) BRPI0810881A2 (pt)
CA (1) CA2683912A1 (pt)
RU (1) RU2490019C2 (pt)
UA (1) UA101316C2 (pt)
WO (1) WO2008127180A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010242498A1 (en) * 2009-05-01 2011-12-22 Micropharma Limited Bacterial compositions for prophylaxis and treatment of degenerative disease
US20110293710A1 (en) 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
RU2460776C9 (ru) * 2011-04-21 2012-11-10 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus acidophilus, используемый для получения продукции, содержащей лактобактерии
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
RU2577994C1 (ru) * 2011-11-30 2016-03-20 Компани Жервэ Данон Реутерин-вырабатывающие lactobacillus brevis
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
ES2711427T3 (es) * 2012-06-04 2019-05-03 Biogaia Ab Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos
EP2904096A1 (en) * 2012-10-03 2015-08-12 Metabogen AB Identification of a person having risk for atherosclerosis and associated diseases by the person's gut microbiome and the prevention of such diseases
JP6088648B2 (ja) * 2013-06-11 2017-03-01 ハウスウェルネスフーズ株式会社 貪食細胞へ物質を送達する担体
GB201319539D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
AU2015341571A1 (en) 2013-11-05 2017-05-18 Optibiotix Limited Prebiotic composition and its method of production
GB201319531D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
GB201319538D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319540D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
CN105062933A (zh) * 2015-09-11 2015-11-18 北京博锦元生物科技有限公司 一种罗伊氏乳杆菌及其应用
JP6986856B2 (ja) * 2016-05-10 2021-12-22 協同乳業株式会社 トリメチルアミンを産生し難い腸内菌叢を形成するためのプロバイオティクス組成物および方法
CN106434427A (zh) * 2016-08-29 2017-02-22 中国疾病预防控制中心传染病预防控制所 乳酸杆菌益生菌cgmcc no.12421及在制备降脂药物中的应用
WO2019227417A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
CN109453152B (zh) * 2018-11-23 2020-10-27 西安交通大学 一种改善主动脉内皮细胞功能的药物及其应用
US20220213493A1 (en) * 2019-05-07 2022-07-07 North Carolina State University Compositions and methods for modulating the gastrointestinal tract using bile salt hydrolases
AU2020352646B2 (en) * 2019-09-26 2025-09-04 Precisionbiotics Group Limited Lactobacillus reuteri
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
CN111588021A (zh) * 2020-05-25 2020-08-28 北京科拓恒通生物技术股份有限公司 一株可缓解和治疗冠心病的乳双歧杆菌Probio-M8及其应用
CN113249249A (zh) * 2021-04-29 2021-08-13 南昌大学 一种具有缓解动脉粥样硬化功效的植物乳杆菌zdy04
CN114410533A (zh) * 2022-01-27 2022-04-29 江南大学 罗伊氏乳杆菌ccfm1040在缓解、预防动脉粥样硬化中的应用
CN120924458B (zh) * 2025-10-16 2026-01-30 新昌县天姥实验室 一种调控巨噬细胞代谢约氏乳杆菌LacY248及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
JP3400282B2 (ja) * 1997-02-21 2003-04-28 株式会社ヤクルト本社 脂質代謝改善剤およびそれを含有する食品
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
JP4598954B2 (ja) * 1998-10-20 2010-12-15 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） 大腸炎処置のためのサイトカイン産生性ラクトコッカス株の使用
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
AUPS194902A0 (en) * 2002-04-24 2002-06-06 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
PL218992B1 (pl) * 2002-07-19 2015-02-27 Abbott Biotech Ltd Neutralizujące o wysokim powinowactwie izolowane ludzkie przeciwciało anty-TNFα, zastosowanie tego przeciwciała, kryształ zawierający ludzkie przeciwciało anty-TNFα i preparat zawierający ten kryształ
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
JP2005336159A (ja) * 2004-04-28 2005-12-08 Univ Kurume Ｎａｄｐｈオキシダーゼ活性を抑制する色素上皮由来因子の新規治療用途
GB0424552D0 (en) * 2004-11-05 2004-12-08 Cambridge Theranostics Ltd Methods and means
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
CA2662710A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation

Also Published As

Publication number Publication date
CA2683912A1 (en) 2008-10-23
EP2136824A4 (en) 2010-12-08
WO2008127180A1 (en) 2008-10-23
US20110081328A1 (en) 2011-04-07
RU2009141617A (ru) 2011-05-20
AU2008239833A2 (en) 2009-11-26
CN101702881A (zh) 2010-05-05
US20080254011A1 (en) 2008-10-16
JP2010523144A (ja) 2010-07-15
AU2008239833A1 (en) 2008-10-23
UA101316C2 (ru) 2013-03-25
KR20100015371A (ko) 2010-02-12
EP2136824A1 (en) 2009-12-30
RU2490019C2 (ru) 2013-08-20

Similar Documents

Publication Publication Date Title
BRPI0810881A2 (pt) Uso de bactérias do ácido lático selecionadas para redução da aterosclerose
BRPI0710944A2 (pt) uso de bactéria selecionada de ácido lático para reduzir cólicas infantis
BRPI1013829A2 (pt) composições e métodos para fermentação de biomassa
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
BRPI0911290A2 (pt) âncora universal para ligar objetos ao tecido ósseo
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
PT2424372T (pt) Composições antimicrobianas e métodos de uso relacionados
HRP20170926T1 (hr) Antisens kompozicije i postupci za pripremu i uporabu istih
BRPI1009982A2 (pt) composição antimicrobiana hidratante
EP2350110A4 (en) NEW STEVIOLGLYKOSIDE
ES2397671T8 (es) Procedimiento para preparar voriconazol
BRPI0920670A8 (pt) composição nutritiva para promover o desenvolvimento e crescimento sadios
FR2942627B1 (fr) Composition de graisse
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
BRPI1011482A2 (pt) composição para uso na redução da transmissão de patógenos humanos
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0808522A2 (pt) Uso de lactobacilus plantarum para aumentar diversidade bacterial
BR112012005680A2 (pt) composição de higiene pessoal
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BRPI0917172A2 (pt) Composição bacteriana
BR112013002123A2 (pt) composição ácida adesiva para limpeza de sanitários e/ou desodorização
BRPI1006024A2 (pt) composição cosmética emulsificada
BRPI1008253A2 (pt) Metoso para tratar biomassa
BRPI0910359A2 (pt) método para inibir o crescimento de microorganismos e composição biocida
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A23L 33/135 (2016.01), A61P

B350 Update of information on the portal [chapter 15.35 patent gazette]